ABBV

2026Q1BMO

AbbVie Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-04-29 · Fiscal end 2026-03-31 · Features as of 2026-04-28

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.67
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.0%
IV front—
P/C full—
P/C front—
Features as of2026-04-28

Run-up

Close—
Ret 5d-3.6%
Ret 10d-6.0%
Ret 20d-7.2%
Ret 30d-10.7%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.65Miss
Estimated EPS2.67
Actual revenue
15.0B
Surprise %-0.7%
Beat / missMiss
Beat streak 40
Beat streak 80

Reaction

1-day stock reaction+6.2%
Implied vs actual

Implied 2.0%Actual 2.9%

Gap reaction-2.9%
Day result+3.1%
Next-day upYes
Realized / IV1.46×

Post tape

Post 5d+0.6%
Post 10d+2.3%
Post volume10.4M
Vol ×10d1.49×
Vol ×20d1.59×
Post range7.9%